Lumenis, which develops and sells laser-based systems used in minimally invasive surgical, ophthalmic and aesthetic procedures, announced terms for its IPO on Thursday. The Yokneam, Israel-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the midpoint of the proposed range, the company would command a fully diluted market value of $597 million. Lumenis, which was founded in 1991 and booked $265 million in sales for the 12 months ended December 31, 2013, plans to list on the NASDAQ under the symbol LMNS. Goldman Sachs, Credit Suisse, and Jefferies are the joint bookrunners on the deal.
